Artal Group S.A. Idera Pharmaceuticals, Inc. Transaction History

Artal Group S.A.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 May 14, 2021	SELL	$1.23 - $5.98 $615,000 - $2.99 Million	-500,000 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$2.09 - $5.18 $1.04 Million - $2.59 Million	500,000 New	500,000 $1.84 Million

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.